Total Payments
$228,391
2024 Payments
$23.80
Companies
11
Transactions
266
Medicare Patients
2,199
Medicare Billing
$204,615
Payment Breakdown by Category
Other$190,266 (83.3%)
Consulting$19,610 (8.6%)
Travel$12,152 (5.3%)
Food & Beverage$6,062 (2.7%)
Education$301.06 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $190,266 | 116 | 83.3% |
| Consulting Fee | $19,610 | 8 | 8.6% |
| Travel and Lodging | $12,152 | 44 | 5.3% |
| Food and Beverage | $6,062 | 89 | 2.7% |
| Education | $301.06 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $69,831 | 54 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $68,573 | 67 | $0 (2021) |
| Lilly USA, LLC | $37,616 | 51 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $33,955 | 56 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,326 | 18 | $0 (2017) |
| Medtronic MiniMed, Inc. | $5,860 | 15 | $0 (2020) |
| Abbott Laboratories | $149.97 | 1 | $0 (2019) |
| Ascensia Diabetes Care Us Inc. | $23.80 | 1 | $0 (2024) |
| Antares Pharma, Inc. | $21.62 | 1 | $0 (2019) |
| MannKind Corporation | $20.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.80 | 1 | Ascensia Diabetes Care Us Inc. ($23.80) |
| 2023 | $3,772 | 5 | Novo Nordisk Inc ($3,752) |
| 2022 | $22,722 | 20 | Novo Nordisk Inc ($22,722) |
| 2021 | $20,020 | 15 | Novo Nordisk Inc ($18,770) |
| 2020 | $24,947 | 20 | Novo Nordisk Inc ($18,522) |
| 2019 | $33,529 | 49 | Janssen Pharmaceuticals, Inc ($14,249) |
| 2018 | $39,321 | 59 | Lilly USA, LLC ($17,997) |
| 2017 | $84,056 | 97 | AstraZeneca Pharmaceuticals LP ($40,573) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 12/08/2023 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 10/19/2023 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 10/06/2023 | MannKind Corporation | AFREZZA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/15/2022 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $64.38 | General |
| Category: Diabetes | ||||||
| 10/31/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $794.75 | General |
| Category: Diabetes | ||||||
| 10/20/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $94.57 | General |
| Category: Diabetes | ||||||
| 08/24/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 06/21/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 06/21/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $116.06 | General |
| Category: Diabetes | ||||||
| 05/04/2022 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 05/04/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $95.77 | General |
| Category: Diabetes | ||||||
| 04/09/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,581.50 | General |
| Category: Diabetes | ||||||
| 04/09/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $524.02 | General |
| Category: Diabetes | ||||||
| 04/09/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $426.18 | General |
| Category: Diabetes | ||||||
| 04/09/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $366.65 | General |
| Category: Diabetes | ||||||
| 04/09/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Travel and Lodging | In-kind items and services | $91.34 | General |
| Category: Diabetes | ||||||
| 02/07/2022 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 02/07/2022 | Novo Nordisk Inc | Victoza (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 648 | 1,031 | $149,761 | $51,894 |
| 2022 | 9 | 466 | 735 | $124,714 | $46,003 |
| 2021 | 9 | 420 | 622 | $112,233 | $44,505 |
| 2020 | 10 | 665 | 961 | $176,309 | $62,212 |
Total Patients
2,199
Total Services
3,349
Medicare Billing
$204,615
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 327 | $84,693 | $31,860 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $14,432 | $4,769 | 33.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 101 | $11,918 | $4,713 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $6,954 | $2,671 | 38.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 51 | 86 | $9,976 | $2,366 | 23.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 150 | 255 | $5,610 | $2,125 | 37.9% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 29 | 44 | $5,280 | $1,929 | 36.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 147 | $9,996 | $1,399 | 14.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 11 | 11 | $902.00 | $62.26 | 6.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 282 | $66,270 | $27,497 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 42 | $13,944 | $5,979 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $15,488 | $5,738 | 37.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 36 | 75 | $8,700 | $2,085 | 24.0% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2022 | 27 | 39 | $4,680 | $1,719 | 36.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 89 | 159 | $10,812 | $1,495 | 13.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 16 | $1,792 | $779.20 | 43.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 25 | 32 | $2,016 | $575.78 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 46 | $1,012 | $135.39 | 13.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 195 | $43,680 | $20,501 | 46.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 60 | $18,960 | $8,244 | 43.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $19,096 | $7,442 | 39.0% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2021 | 30 | 51 | $6,120 | $2,302 | 37.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $4,928 | $1,964 | 39.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 30 | 56 | $6,496 | $1,668 | 25.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 36 | 65 | $4,095 | $1,195 | 29.2% |
About Dr. Aaron Benjamin, MD
Dr. Aaron Benjamin, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699954537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Benjamin, MD has received a total of $228,391 in payments from pharmaceutical and medical device companies, with $23.80 received in 2024. These payments were reported across 266 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($190,266).
As a Medicare-enrolled provider, Benjamin has provided services to 2,199 Medicare beneficiaries, totaling 3,349 services with total Medicare billing of $204,615. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Chicago, IL
- Active Since 10/28/2007
- Last Updated 04/26/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1699954537
Products in Payments
- FARXIGA (Drug) $51,361
- INVOKANA (Drug) $33,813
- Ozempic (Drug) $23,703
- RYBELSUS (Drug) $22,260
- Rybelsus (Drug) $17,681
- TRULICITY (Drug) $17,608
- BYDUREON (Drug) $17,212
- JARDIANCE (Drug) $15,327
- BASAGLAR (Drug) $13,753
- Tresiba (Drug) $3,563
- Victoza (Drug) $1,668
- Minimed 670G System (Device) $1,227
- FreeStyle Lite system (Device) $149.97
- XARELTO (Drug) $136.16
- EVERSENSE E3 SENSOR KIT - RETAIL (Device) $23.80
- XYOSTED (Drug) $21.62
- AFREZZA (Drug) $20.00
- Tecnis 1-piece IOL (Device) $14.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Chicago
Wahid Kassar, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Endocrinology, Diabetes & Metabolism $1.3M
David Oyer, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $272,437
Endocrinology, Diabetes & Metabolism $272,437
Dr. Grazia Aleppo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $179,656
Endocrinology, Diabetes & Metabolism $179,656
Silvana Pannain
Endocrinology, Diabetes & Metabolism — Payments: $176,625
Endocrinology, Diabetes & Metabolism $176,625
Mark Molitch, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $105,398
Endocrinology, Diabetes & Metabolism $105,398
Tamara Vokes
Endocrinology, Diabetes & Metabolism — Payments: $105,216
Endocrinology, Diabetes & Metabolism $105,216